Business
Bio Spectrum
VeGen Labs secures BIRAC funding of Rs 3.76 Cr to advance KRAS inhibitor
Hyderabad-based biotechnology startup VeGen Labs LLP has been awarded Rs 3.765 crore Royalty-based financial support from Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise set-up by Department of Biotechnology.
1 min |
BioSpectrum India April 2025
Bio Spectrum
Vydehi Instituteof Medical Sciencesand Research Centreto expand access to robotic-assisted surgery
Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, a leading institution in multi-speciality tertiary care, has joined hands with Intuitive, a global technology leader in minimally invasive care and the pioneer of roboticassisted surgery (RAS), to introduce resident surgeons to robotic-assisted surgical technology through the Intuitive Robotic Onboarding Programme and Education (I-ROPE).
1 min |
BioSpectrum India April 2025
Bio Spectrum
"CSIR's strategic priorities will focus on indigenisation, healthcare innovation, and bio-based economic growth"
National Science Day is celebrated every year on February 28 to spread the message of the importance of science and its application in the country.
5 min |
BioSpectrum India April 2025
Bio Spectrum
CDSCO approves AstraZeneca to import SZC for treatment of Hyperkalaemia in adults
AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India to import pharmaceutical formulations of new drug for sale or distribution for Sodium Zirconium Cyclosilicate (SZC) powder - oral suspension 5g and 10g.
1 min |
BioSpectrum India April 2025
Bio Spectrum
WHO announces new collaborating centre on AI for health governance
The World Health Organization (WHO) has designated the Digital Ethics Centre at Delft University of Technology in the Netherlands as a WHO Collaborating Centre on artificial intelligence (AI) for health governance.
1 min |
BioSpectrum India April 2025
Bio Spectrum
"We aim to position India as a leader in personalised medicine and drive future innovations"
The landscape of cell and gene therapy (CGT) in India is rapidly evolving, with significant advancements poised to revolutionise patient care.
5 min |
BioSpectrum India April 2025
Bio Spectrum
NIT Rourkela develops AI-powered model to improve blood sugar predictions for diabetes management
A research team at National Institute of Technology (NIT) Rourkela has developed a new artificial intelligence (AI)driven approach to improve blood sugar predictions for people with diabetes.
1 min |
BioSpectrum India April 2025
Bio Spectrum
Global companies to open new centres across life sciences and tech sectors in Hyderabad
A series of announcements were made by global companies at the 22nd edition of BioAsia 2025, Asia’s largest life sciences and healthcare conference organized by the Department of Industries & Commerce, Government of Telangana on the theme ‘Catalysts of Change – Expanding Global Healthcare Frontiers, Transforming Healthcare with Innovation, Collaboration and Progress’.
1 min |
BioSpectrum India April 2025
Bio Spectrum
Paras Health elevates Vineet Aggarwal to Group COO
Paras Health, based in Gurugram, has announced the elevation of Vineet Aggarwal to Group Chief Operating Officer (GCOO), effective immediately.
1 min |
BioSpectrum India April 2025
Bio Spectrum
"It's important for healthcare.startups in India to recognise the price sensitiveness of the market"
Chandigarh-based startup RNT Health, recognised for its groundbreaking innovations, including the recent US FDA Breakthrough Device Designation for an oesophageal cancer detection tool, has launched its Automated Endoscopy Report Generation software to streamline manual reporting workflows in endoscopy suites.
4 min |
BioSpectrum India April 2025
Bio Spectrum
Industry Leaders Drive CRDMO Reform, Unite Under IPSO for a Transformational Leap
Due to lack of a clear and unified industry definition and slowing progress, the CRDMO industry leaders joined hands and formed Innovative Pharmaceutical Services Organization (IPSO) at the recently concluded BioAsia-2025 to create a strategic blueprint—a roadmap to define the CRDMO sector and position India as a global leader in biopharma outsourcing.
7 min |
BioSpectrum India April 2025
Bio Spectrum
Trump's Tariff Tactics
The Indo-US trade turbulence triggered by US President Donald Trump's repeated statements over reciprocal trade tariffs continues to be a cause for concern.
2 min |
BioSpectrum India April 2025
Bio Spectrum
IIT-M Pravartak partners with Agilisium to accelerate research in life sciences and healthcare
The Indian Institute of Technology Madras (IIT-M) Pravartak Technologies Foundation has entered into a strategic partnership with Agilisium, a leading data innovation partner for life sciences companies, to accelerate research in life sciences and healthcare endeavours.
1 min |
BioSpectrum India April 2025
Bio Spectrum
WHO releases first technical brief on Encephalitis
The World Health Organization (WHO) and Encephalitis International have launched a critical Technical Brief on Encephalitis in London, which identified encephalitis (infectious and autoimmune) as an increasing global threat making it an urgent public health priority.
1 min |
BioSpectrum India April 2025
Bio Spectrum
Creating a Future Ready Pharma QC and Microbiology Ecosystem
According to the India Skills Report, the pharma industry had a high skill gap in quality control (QC) and other critical areas, with an employability rate of 37 per cent, far lower than the 46 per cent national average.
5 min |
BioSpectrum India April 2025
Bio Spectrum
"Implementation of Rapid Microbiological Methods will play a vital role in contributing to the Global Health for drugs"
The inaugural BioLuminescence 2025 event by Merck took place in Ahmedabad on February 20, serving as a pivotal platform to enhance engagement with regulatory bodies, key opinion leaders, and stakeholders in the pharmaceutical industry.
5 min |
BioSpectrum India April 2025
Bio Spectrum
Biocon Biologics and Civica collaborate to expand insulin Aspart access in US
Bengaluru-based Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, and Civica, Inc., a not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, have announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States (US).
1 min |
BioSpectrum India April 2025
Bio Spectrum
Accelerating Pharma Innovation: Leveraging Virtualisation for Compliance and Efficiency in the Age of DPDP
The pharmaceutical sector is moving toward a digital-first future, and virtualisation will be the foundation of safe and legal operations.
5 min |
BioSpectrum India April 2025
Bio Spectrum
KKR acquires controlling stake in Healthcare Global Enterprises for 400 M
KKR, a leading global investment firm, and Bengaluru-based Healthcare Global Enterprises have announced the signing of definitive agreements with CVC, a leading global private markets manager, under which funds managed by KKR will become the largest shareholder in HCG and assume sole control of HCG’s operations.
1 min |
BioSpectrum India April 2025
Bio Spectrum
How Indian Pharma Prepared.to Mitigate US Tariffs...!
India, known as the pharmacy of the world, has an upper hand when it comes to facing the US tariff war. Indian pharmaceutical companies supply nearly 47 per cent of the generic medicines for the American patients and contribute significantly to the country's healthcare savings. Imposing a 25 per cent or more tariff on Indian pharma companies can be detrimental for the US administration. More so, a reciprocal tariff by the Indian government can add to the woes of the US. However, Indian companies should take a note of the tariff and take proactive steps to be safe from high tariffs.
7 min |
BioSpectrum India April 2025
Bio Spectrum
"We plan to establish a CoE in medtech and launch a bio-innovation acceleration programme in 2025"
Karnataka State Cabinet has recently approved funding allocations of over Rs 350 crore for technology and innovation development across the state, which includes seed funding for startups.
2 min |
BioSpectrum India April 2025
Bio Spectrum
Bhavin Mukund Mehta Vice-Chairman steps in as of Pharmexcil
Pharmaceuticals Export Promotion Council of India (Pharmexcil), a leading authorised body of the Government of India for promotion of pharmaceutical exports from India has appointed Bhavin Mukund Mehta, Wholetime Director, Kilitch Drugs (India) Limited as the Vice-Chairman of the council.
1 min |
March 2025
Bio Spectrum
Roche Pharma India appoints Rajwinder Mehdwan as new Country General Manager
Roche Pharma India has announced the appointment of Rajwinder (Rajji) Mehdwan as country General Manager, effective April 1, 2025. She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian Subcontinent) region leadership team, reporting to Francois du Toit, Area Head of CEETRIS, Roche Pharmaceuticals.
1 min |
March 2025
Bio Spectrum
Exploring Careers in Clinical Research: Pathways, Roles, and Future Prospects in India
With India's evolving regulatory landscape, business environment and technological advancements, the future of clinical research in the country is promising and full of potential. This is creating the demand for proficient researchers which is increasing and offering exciting career opportunities for individuals prepared to influence the future of Medicines, Vaccines, Diagnostics, and Medical Devices.
4 min |
March 2025
Bio Spectrum
Biopharma Chromatography: Segregating Opportunities of all Sizes
Chromatography systems are essential in a variety of fields, including the biological sciences. Biopharma accounts for almost 30 per cent of this market, making it a key sector for chromatography systems. The main forces behind India's dominant market position would be the enabling government policies and the growing number of foreign research and industrial contracts. Beginning in 2028, India will create a demand for more than 1000 biopharma chromatography systems yearly.
4 min |
March 2025
Bio Spectrum
We're on a mission to make India a global leader in Frontier Tech: Debjani Ghosh
“From AI breakthroughs revolutionising healthcare to bioengineering innovations addressing food security and renewable energy advancements driving sustainability, Frontier Technologies offer solutions to the world’s most pressing challenges,” said Debjani Ghosh, Distinguished Fellow & Chief Architect - NITI Frontier Tech Hub, NITI Aayog, New Delhi.
2 min |
March 2025
Bio Spectrum
10 Women 'Power Players' of Bio Research & Policy
As revealed in Finance Minister Nirmala Sitharaman's Economic Survey 202425, for the first time in seven years, India’s female labour force participation rate (FLFPR) has seen a significant rise, jumping from 23.3 per cent in 2017-18 to 41.7 per cent in 2023-24.
10+ min |
March 2025
Bio Spectrum
"We recognise the growing demand for skilled talent in fields like Al, Gen Al, Robotics, and Data Analytics"
Takeda, a global leader in biopharmaceutical innovation from Japan has opened its Innovation Capability Center (ICC) in Bengaluru.
5 min |
March 2025
Bio Spectrum
Metropolis & Roche introduce HPV DNA testing to accelerate cervical cancer screening
Metropolis Healthcare has announced its collaboration with Roche Diagnostics India and Neighbouring Markets to introduce the self-sampling human papillomavirus (HPV) DNA test for cervical cancer screening.
1 min |
March 2025
Bio Spectrum
Shimadzu strengthens business operations in India with new plant in Bengaluru
In order to strengthen business operations in India, which is expected to experience high economic growth, Japan's Shimadzu Corporation will establish the manufacturing subsidiary Shimadzu Manufacturing India Private Limited (SMI) in Bengaluru, Karnataka.
1 min |